Tin tức & Cập nhật
Xem bài viết Da liễu
Xem
Chỉ hiển thị Multimedia

Ixekizumab effective for difficult-to-treat psoriatic arthritis
08 Dec 2021
bởiAudrey Abella
The monoclonal antibody ixekizumab improved the signs and symptoms of psoriatic arthritis (PsA) in PsA patients with inadequate response to one or two tumour necrosis factor inhibitors (TNFis), suggests results from a post hoc subanalysis of the SPIRIT-P2 trial.
08 Dec 2021







